Coeptis Therapeutics Inc.

COEP | NASDAQ

Price Alert Chart Builder DCF Calculator

$10.99

$0.00 (0.00%)

Nov 2, 2026, 1:39 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $38.62M

Enterprise Value $23.12M

Beta -0.43

Average Volume 52.54K

Shares Outstanding (Diluted) 49.76M

Shares Change YoY 1242.37%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US98878K1088

Price Performance

Price Change 1M N/A

Price Change 3M N/A

Price Change 6M -9.2%

Price Change YTD -24.9%

Price Change 1Y -32.6%

Price Change 3Y -55.0%

Price Change 5Y -94.5%

1M CAGR (ann.) 35.9%

1Y CAGR (ann.) 42.6%

5Y CAGR (ann.) -39.3%

All-Time CAGR -37.2%

Valuation

PE Ratio -6.11

Forward PE N/A

PEG Ratio -0.15

Forward PEG -0.15

PS Ratio 13.81

Forward PS 50.40

PB Ratio 0.29

P/FCF Ratio -9.55

P/Adj. FCF Ratio -3.42

P/OCF Ratio -137.38

EV/Sales 8.27

EV/EBIT -2.97

EV/EBITDA -1.12

EV/FCF -5.72

Earnings Yield -16.4%

FCF Yield -10.5%

Adj. FCF Yield -29.2%

Financial Health

Net Cash $15.49M

Total Debt $0

Cash & Short-Term Investments $15.49M

Total Assets $134.51M

Current Ratio 7.66

Quick Ratio 7.66

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage -43.64

Altman Z-Score 11.24

Piotroski F-Score 4

Margins & Profitability

Gross Profit Margin 16.8%

Operating Profit Margin -792.9%

EBITDA Margin -738.8%

Net Profit Margin -788.8%

FCF Margin -144.6%

Adj. FCF Margin -403.7%

SBC / Revenue 259.1%

SBC Impact (per share) -179.3%

Returns

Return on Assets -16.4%

Return on Equity -48.2%

Return on Invested Capital -16.7%

Return on Capital Employed -16.7%

Return on Tangible Assets -80.0%

Historical Growth (CAGR)

Revenue CAGR 3Y 137.1%

Revenue CAGR 5Y 106.2%

Revenue CAGR 10Y N/A

EPS CAGR 3Y -36.4%

EPS CAGR 5Y 100.0%

EPS CAGR 10Y N/A

FCF CAGR 3Y 23.0%

FCF CAGR 5Y 22.1%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date May 14, 2026

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-4.04M

Free Cash Flow $-4.04M

Adj. Free Cash Flow $-11.29M

FCF Per Share -$0.08

OCF Per Share -$0.08

OCF/S Ratio -144.6%

Income Statement

Revenue $2.8M

Gross Profit $469.36K

Operating Income $-22.17M

EBITDA $-20.71M

Net Income $-22.06M

EPS (Diluted) -$1.80

Revenue / Employee $466.12K

Profit / Employee $-3.68M

Employees 6